Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. GOOGL
6. RTX
7. COF
8. SMCI
9. TSLA
10. BRZE

Go back to Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025

Bristol-Myers Squibb (BMY) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY26 Guidance

February 5, 2026 7:00 AM EST

Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $1.26, $0.14 better than the analyst estimate of $1.12. Revenue for the quarter came in at $12.5 billion versus the consensus estimate of $12.24 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2026 EPS of $6.05-$6.35, versus the consensus of $6.02.... More